dc.contributor.advisor | Bastidas Goyes, Alirio Rodrigo | |
dc.contributor.advisor | Reyes Velasco, Luis Felipe | |
dc.contributor.advisor | Jaimes Mantilla, Anyelinne | |
dc.contributor.advisor | Ramírez Torra, Silvia Margarita | |
dc.contributor.author | Frías Ordoñez, Juan Sebastián | |
dc.contributor.author | Aguilar Chacón, Álvaro Fernando | |
dc.date.accessioned | 2021-02-26T17:06:09Z | |
dc.date.available | 2021-02-26T17:06:09Z | |
dc.date.issued | 2021-02-08 | |
dc.identifier.uri | http://hdl.handle.net/10818/46973 | |
dc.description | 97 páginas | es_CO |
dc.description.abstract | Objetivo: Valorar el desempeño de la puntaje CORB en sujetos con neumonía adquirida en la comunidad (NAC) en relación a la predicción de muerte intrahospitalaria, muerte a 30 días, requerimiento de ventilación mecánica (VM) y soporte vasopresor. Metodología: Estudio de cohorte retrospectiva con análisis de prueba diagnóstica de los puntajes CORB (Confusión, oxigenación: SpO2 ≤ 90% o SpO2/FiO2<300, frecuencia respiratoria (FR), presión arterial) y CURB-65. Se consideró neumonía adquirida en la comunidad (NAC) según la definición ATS/IDSA, se calcularon los odds ratio crudos y ajustados de cada variable utilizada en la construcción de los puntajes con los desenlaces evaluados, y se construyeron las áreas bajo la curva ROC (ACOR), sensibilidad, especificidad, valor predictivo positivo y negativa, razón de verosimilitud positiva y negativa de cada una de las curvas con los desenlaces de muerte intrahospitalaria, muerte a 30 días, requerimiento de soporte vasopresor y requerimiento de ventilación mecánica. | es_CO |
dc.description.abstract | Objective: To assess the performance of the CORB score in subjects with
community-acquired pneumonia (CAP) in relation to the prediction of in-hospital
death, death at 30 days, requirement of mechanical ventilation (MV) and
vasopressor support.
Materials and methods: Retrospective cohort study with analysis of CORB scores
(Confusion, oxygenation: SpO2 ≤ 90% or SpO2 / FiO2 <300, respiratory rate (RR),
blood pressure) and CURB-65. Community acquired pneumonia (CAP) was
considered according to the ATS / IDSA definition, the crude and adjusted relative
risks of each variable used in the construction of the scores with the evaluated
outcomes were calculated, and the areas under the ROC curve (AUC), sensitivity,
specificity, positive and negative predictive value, positive and negative likelihood
ratio of each of the curves with the outcomes of in-hospital death, death at 30 days,
requirement for vasopressor support and mechanical ventilation. | eng |
dc.format | application/pdf | es_CO |
dc.language.iso | spa | es_CO |
dc.publisher | Universidad de La Sabana | es_CO |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.source | instname:Universidad de La Sabana | es_CO |
dc.source | reponame:Intellectum Repositorio Universidad de La Sabana | es_CO |
dc.title | Desempeño del índice Corb (confusión, oxigenación, frecuencia respiratoria, y presión arterial) como puntaje alternativo para la predicción de complicaciones en neumonía | es_CO |
dc.type | bachelorThesis | es_CO |
dc.identifier.local | 280874 | |
dc.identifier.local | TE11158 | |
dc.type.hasVersion | publishedVersion | es_CO |
dc.rights.accessRights | restrictedAccess | es_CO |
dc.subject.armarc | Neumonía | spa |
dc.subject.armarc | Unidades de cuidados intensivos | spa |
dc.subject.armarc | Respiración artificial | spa |
dc.subject.decs | Vasoconstrictores | spa |
dc.subject.decs | Hipoxia | spa |
dcterms.references | Heron M. Deaths: Leading causes for 2015. Natl Vital Stat Reports.
2017;66(5). | en |
dcterms.references | WHO. Top ten causes of death. Top ten causes of death [Internet]. 2018;1–
8. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top10-causes-of-death | en |
dcterms.references | Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, et
al. Adults Hospitalized with Pneumonia in the United States: Incidence,
Epidemiology, and Mortality. Clin Infect Dis. 2017;65(11):1806–12. | en |
dcterms.references | Fine MJ, Auble TE , Yealy DM , Hanusa BH, Weissfeld LA , Singer DE ,
Coley CM , Marrie TJ KW. A predicition rule to indetify low-risk patients with
community acquired pneumonia. N Engl J Med. 1997;336(4):243–50 | en |
dcterms.references | Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI,
Lewis SA MJ. Defining community acquired pneumonia severity on
presentation to hospital: An international derivation and validation study.
Thorax. 2003;58(5):377–82 | en |
dcterms.references | Marti C, Garin N, Grosgurin O, Poncet A, Combescure C, Carballo S, et al.
Prediction of severe community-acquired pneumonia: A systematic review
and meta-analysis. Crit Care [Internet]. 2012;16(4):R141. Available from:
http://ccforum.com/content/16/4/R141 | en |
dcterms.references | Woodhead M, Welch CA, Harrison DA, Bellingan G, Ayres JG. Communityacquired pneumonia on the intensive care unit: Secondary analysis of 17,869
cases in the ICNARC Case Mix Programme Database. Crit Care.
2006;10(SUPPL. 2). | en |
dcterms.references | Restrepo MI, Mortensen EM, Rello J, Brody J, Anzueto A. Late admission to
the ICU in patients with community-acquired pneumonia is associated with
higher mortality. Chest. 2010;137(3):552–7. | en |
dcterms.references | Buising KL, Thursky KA, Black JF, MacGregor L, Street AC, Kennedy MP, et
al. A prospective comparison of severity scores for identifying patients with
severe community acquired pneumonia: Reconsidering what is meant by
severe pneumonia. Thorax. 2006;61(5):419–24. | en |
dcterms.references | Quintana JM, Areitio I, Gorordo I, Capelastegui A, Espan PP, Egurrola M, et
al. Validation of a predictive rule for the management of community-acquired
pneumonia ˜. Eur Respir J. 2006;27:151–7. | en |
dcterms.references | Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al.
Diagnosis and treatment of adults with community-acquired pneumonia. Am
J Respir Crit Care Med. 2019;200(7):E45–67. | en |
dcterms.references | Lim WS, Baudouin S, George R, Hill A, Jamieson C, Le Jeune I, et al. British
Thoracic Society guidelines for the management of community acquired
pneumonia in adults: Update 2009. Thorax. 2009;64(SUPPL. 3) | en |
dcterms.references | Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB,
et al. Management of Adults With Hospital-acquired and Ventilatorassociated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious
Diseases Society of America and the American Thoracic Society. Clin Infect
Dis. 2016;63(5):e61–111. | en |
dcterms.references | Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P,
Hanberger H, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated
pneumonia. Eur Respir J. 2017;50(3) | en |
dcterms.references | Moreno Claudia RY. Analisis De Situación De Salud ( ASIS ) Dirección de
Epidemiología y Demografía. Minist salud [Internet]. 2018;1–143. Available
from:
https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/PS
P/asis-nacional-2017.pdf | es_CO |
dcterms.references | Montufar FE, Varón FA, Sáenz OA. Infectio Asociación Colombiana de
Infectología Recomendaciones para el diagnóstico , tratamiento y
prevención de la neumonía adquirida en la comunidad en adultos
Recommendations for diagnosis , treatment and prevention of communityacquired pneumonia in i. Infectio. 2013;17(Supl 1):1–38 | es_CO |
dcterms.references | Marrie TJ, Mapplsc JQH. Epidemiology of community-acquired pneumonia in
Edmonton, Alberta. 2015;12(3):139–43. | en |
dcterms.references | Medicare.gov - Hospital Compare..pdf. | en |
dcterms.references | Alí, A, Ortiz, G, Dueñas C. Concenso Colombiano de neumonia nosocomial
2013. 2013;17(1):6–18. | es_CO |
dcterms.references | Magill SS, O’Leary E, Janelle SJ, Thompson DL, Dumyati G, Nadle J, et al.
Changes in prevalence of health care-associated infections in U.S. Hospitals.
N Engl J Med. 2018;379(18):1732–44. | en |
dcterms.references | Metersky ML, Wang Y, Klompas M, Eckenrode S, Bakullari A, Eldridge N.
Trend in ventilator-associated pneumonia rates between 2005 and 2013.
JAMA - J Am Med Assoc. 2016;316(22):2427–9. | en |
dcterms.references | Wunderink RG, Waterer GW. Community-acquired pneumonia. N Engl J
Med. 2014;370(6):543–51. | en |
dcterms.references | Wang Y, Wang Y, Chen Y QQ. Unique epidemiological and clinical features
of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate
special control measures. J Med Virol. 2020;92:568– 576. | en |
dcterms.references | Xie J, Covassin N, Fan Z, Singh P, Gao W, Li G, et al. Association Between
Hypoxemia and Mortality in Patients With COVID-19. Mayo Clin Proc
[Internet]. 2020;1–10. Available from:
https://doi.org/10.1016/j.mayocp.2020.04.006 | en |
dcterms.references | Cillóniz C, Polverino E, Ewig S, Aliberti S, Gabarrús A, Menéndez R, et al.
Impact of age and comorbidity on cause and outcome in community-acquired
pneumonia. Chest. 2013;144(3):999–1007 | en |
dcterms.references | Torres A, Peetermans WE, Viegi G, Blasi F. Risk factors for communityacquired pneumonia in adults in Europe: A literature review. Thorax.
2013;68(11):1057–65. | en |
dcterms.references | Ito A, Ishida T, Tokumasu H, Washio Y, Yamazaki A, Ito Y, et al. Prognostic
factors in hospitalized community-acquired pneumonia: A retrospective study
of a prospective observational cohort. BMC Pulm Med. 2017;17(1):1–10 | en |
dcterms.references | Li JS, Hou ZK, Yu XQ, Li SY, Sun ZK, Zhang W, et al. Prognostic factors for
community-acquired pneumonia in middle-aged and elderly patients treated
with integrated medicine. J Tradit Chinese Med [Internet]. 2012;32(2):179–
86. Available from: http://dx.doi.org/10.1016/S0254-6272(13)60008-4 | en |
dcterms.references | Zalacain R, Torres A, Celis R, Blanquer J, Aspa J, Esteban L, et al.
Community-acquired pneumonia in the elderly: Spanish multicentre study.
57
Eur Respir J. 2003;21(2):294–302 | en |
dcterms.references | Waterer GW, Kessler LA, Wunderink RG. Delayed administration of
antibiotics and atypical presentation in community-acquired pneumonia.
Chest [Internet]. 2006;130(1):11–5. Available from:
http://dx.doi.org/10.1378/chest.130.1.11 | en |
dcterms.references | Musher DM, Roig IL, Cazares G, Stager CE, Logan N, Safar H. Can an
etiologic agent be identified in adults who are hospitalized for communityacquired pneumonia: Results of a one-year study. J Infect [Internet].
2013;67(1):11–8. Available from: http://dx.doi.org/10.1016/j.jinf.2013.03.003 | en |
dcterms.references | Alves dos Santos JW, Torres A, Trindade Michel G, Cornelius de Figueiredo
CW, Nascimento Mileto J, Gentil Foletto V, et al. Non-infectious and unusual
infectious mimics of community-acquired pneumonia. Respir Med.
2004;98(6):488–94 | en |
dcterms.references | Cukic V, Hadzic A. The Most Common Detected Bacteria in Sputum of
Patients with Community Acquired Pneumonia (CAP) Treated In Hospital.
Med Arch (Sarajevo, Bosnia Herzegovina). 2016;70(5):354–8. | en |
dcterms.references | Zhang D, Yang D, Makam AN. Utility of Blood Cultures in Pneumonia. Am J
Med. 2019;132(10):1233–8. | en |
dcterms.references | Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB, et
al. A guide to utilization of the microbiology laboratory for diagnosis of
infectious diseases: 2013 recommendations by the infectious diseases
society of America (IDSA) and the American Society for Microbiology (ASM).
Clin Infect Dis. 2013;57(4) | en |
dcterms.references | Uematsu H, Hashimoto H, Iwamoto T, Horiguchi H, Yasunaga H. Impact of
guideline-concordant microbiological testing on outcomes of pneumonia. Int
J Qual Heal Care. 2014;26(1):100–7. | en |
dcterms.references | Watkins RR, Lemonovich TL. Diagnosis and management of community acquired pneumonia in adults. Am Fam Physician. 2011;83(11):1299–306. | en |
dcterms.references | Loeffelholz MJ, Tang YW. Laboratory diagnosis of emerging human
coronavirus infections–the state of the art. Emerg Microbes Infect.
2020;9(1):747–56. | en |
dcterms.references | Saavedra Trujillo CH. Resumen: Consenso colombiano de atención,
diagnóstico y manejo de la infección por SARS-COV-2/COVID-19 en
establecimientos de atención de la salud - Recomendaciones basadas en
consenso de expertos e informadas en la evidencia. Infectio. 2020;24(3) | es_CO |
dcterms.references | Chen H, Weng H, Lin M, He P, Li Y, Xie Q, et al. The Clinical Significance of
FilmArray Respiratory Panel in Diagnosing Community-Acquired Pneumonia.
Biomed Res Int. 2017;2017. | en |
dcterms.references | Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC,
et al. Infectious Diseases Society of America/American Thoracic Society
Consensus Guidelines on the Management of Community-Acquired
Pneumonia in Adults. Clin Infect Dis. 2007;44(Supplement_2):S27–72. | en |
dcterms.references | Lim WS, Van Der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI,
et al. Defining community acquired pneumonia severity on presentation to
hospital: An international derivation and validation study. Thorax.
2003;58(5):377–82. | en |
dcterms.references | Lim WS, Lewis S, Macfarlane JT. Severity prediction rules in community | en |
dcterms.references | Lim WS, Macfarlane JT, Boswell TCJ, Harrison TG, Rose D, Leinonen M, et
al. Study of community acquired pneumonia aetiology (SCAPA) in adults
admitted to hospital: Implications for management guidelines. Thorax.
2001;56(4):296–301. | en |
dcterms.references | Renaud B, Coma E, Labarere J, Hayon J, Roy P, Boureaux H, et al. Routine
Use of the Pneumonia Severity Index for Guiding the Site‐of‐Treatment
Decision of Patients with Pneumonia in the Emergency Department: A
Multicenter, Prospective, Observational, Controlled Cohort Study. Clin Infect
Dis. 2007;44(1):41–9. | en |
dcterms.references | Gonzalez C, Johnson T, Rolston K, Merriman K, Warneke C, Evans S.
Predicting pneumonia mortality using CURB-65, PSI, and patient
characteristics in patients presenting to the emergency department of a
comprehensive cancer center. Cancer Med. 2014;3(4):962–70. | en |
dcterms.references | Macfarlane J, Boswell T DG. BTS guidelines for management of communityacquired pneumonia in adults—2004 update. Br Thorac Soc.
2004;59(5):361–3. | en |
dcterms.references | Buising KL, Thursky KA, Black JF, Macgregor L, Street AC, Marcus P.
Identifying severe community-acquired pneumonia in the emergency
department : A simple clinical prediction tool Objective : Methods : Results :
Conclusion : Emerg Med Australas. 2007;18:418–26. | en |
dcterms.references | Charles PGP, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, et al.
SMART‐COP: A Tool for Predicting the Need for Intensive Respiratory or
Vasopressor Support in Community‐Acquired Pneumonia. Clin Infect Dis.
2008;47(3):375–84 | en |
dcterms.references | Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, et al.
Guidelines for the management of adult lower respiratory tract infections -
Full version. Clin Microbiol Infect [Internet]. 2011;17:E1–59. Available from:
http://dx.doi.org/10.1111/j.1469-0691.2011.03672.x | en |
dcterms.references | File TM, Marrie TJ. Burden of community-acquired pneumonia in North
American adults. Postgrad Med. 2010;122(2):130–41. | en |
dcterms.references | Jordi Carratalá, Núria Fernandez-Sabe, Lucia Ortega, Xavier Castellsagué,
Beatriz Rosón, Jordi Dorca AFA. Outpatient Care Compared with
Hospitalization for. Ann Intern Med. 2005;142:165–72 | en |
dcterms.references | McNally M, Curtain J, O’Brien KK, Dimitrov BD, Fahey T. Validity of British
Thoracic Society guidance (the CRB-65 rule) for predicting the severity of
pneumonia in general practice: Systematic review and meta-analysis. Br J
Gen Pract. 2010;60(579):423–33. | en |
dcterms.references | Bauer TT, Ewig S, Marre R, Suttorp N, Welte T. CRB-65 predicts death from
community-acquired pneumonia. J Intern Med. 2006;260(1):93–101. | en |
dcterms.references | Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Summary of
Canadian guidelines for the initial management of community-acquired
pneumonia: An evidence-based update by the Canadian infectious disease
society and the Canadian thoracic society. Can Respir J. 2000;7(5):371–82. | en |
dcterms.references | Choudhury G, Chalmers JD, Mandal P, Akram AR, Murray MP, Short P, et
al. Physician judgement is a crucial adjunct to pneumonia severity scores in
low-risk patients. Eur Respir J. 2011;38(3):643–8. | en |
dcterms.references | Chalmers JD, Singanayagam A, Akram AR, Mandal P, Short PM, Choudhury
G, et al. Severity assessment tools for predicting mortality in hospitalised
patients with community-acquired pneumonia. Systematic review and metaanalysis. Thorax. 2010;65(10):878–83. | en |
dcterms.references | Loke YK, Kwok CS, Niruban A, Myint PK. Value of severity scales in
predicting mortality from community-acquired pneumonia: Systematic review
and meta-analysis. Thorax. 2010;65(10):884–90. | en |
dcterms.references | Akram AR, Chalmers JD, Hill AT. Predicting mortality with severity
assessment tools in out-patients with community-acquired pneumonia. Qjm.
2011;104(10):871–9. | en |
dcterms.references | Majumdar SR, Eurich DT, Gamble JM, Senthilselvan A, Marrie TJ. Oxygen
saturations less than 92% are associated with major adverse events in
outpatients with pneumonia: A population-based cohort study. Clin Infect Dis.
2011;52(3):325–31 | en |
dcterms.references | Halm EA, Atlas SJ, Borowsky LH, Benzer TI, Metlay JP, Chang Y, et al.
Understanding Physician Adherence With a Pneumonia Practice Guideline.
Arch Intern Med. 2000;160(1):98. | en |
dcterms.references | Chalmers JD, Taylor JK, Singanayagam A, Fleming GB, Akram AR, Mandal
P, et al. Epidemiology, antibiotic therapy, and clinical outcomes in health
care-associated pneumonia: A UK cohort study. Clin Infect Dis.
2011;53(2):107–13. | en |
dcterms.references | Kolditz M, Ewig S, Schütte H, Suttorp N, Welte T, Rohde G. Assessment of
oxygenation and comorbidities improves outcome prediction in patients with
community-acquired pneumonia with a low CRB-65 score. J Intern Med.
2015;278(2):193–202. | en |
dcterms.references | Dwyer R, Hedlund J, Henriques-Normark B, Kalin M. Improvement of CRB65 as a prognostic tool in adult patients with community-acquired
pneumonia. BMJ Open Respir Res. 2014;1(1):1–7. | en |
dcterms.references | Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ.
Cardiac complications in patients with community-acquired pneumonia
incidence, timing, risk factors, and association with short-term mortality.
Circulation. 2012;125(6):773–81. | en |
dcterms.references | Aliberti S, Ramirez J, Cosentini R, Valenti V, Voza A, Rossi P, et al. Acute
myocardial infarction versus other cardiovascular events in
communityacquired pneumonia. ERJ Open Res [Internet]. 2015;1(1):1–9.
Available from: http://dx.doi.org/10.1183/23120541.00020-2015 | en |
dcterms.references | Dwyer R, Hedlund J, Darenberg J, Henriques-Normark B, Naucler P,
Runesdotter S, et al. Improvement of CRB-65 as a prognostic scoring
system in adult patients with bacteraemic pneumococcal pneumonia. Scand
J Infect Dis. 2011;43(6–7):448–55. | en |
dcterms.references | Welte T, Torres A, Nathwani D. Clinical and economic burden of communityacquired pneumonia among adults in Europe. Thorax. 2012;67(1):71– | en |
dcterms.references | Bartlett JG ML. Current concepts community-acquired pneumonia. N Engl J
Med. 1995;222:1618–24. | en |
dcterms.references | Saldías Peñafiel F, O’Brien Solar A, Gederlini Gollerino A, Farías Gontupil G,
Díaz Fuenzalida A. Neumonía adquirida en la comunidad en el anciano
inmunocompetente que requiere hospitalización. Cuadro clínico, factores
60
pronósticos y tratamiento. Arch Bronconeumol. 2003;39(8):333–40. | es_CO |
dcterms.references | Potgieter PD, Hammond JMJ. The intensive care management, mortality and
prognostic indicators in severe community-acquired pneumococcal
pneumonia. Intensive Care Med. 1996;22(12):1301–6. | en |
dcterms.references | Lee JH, Kim J, Kim K, Jo YH, Rhee JE, Kim TY, et al. Albumin and Creactive protein have prognostic significance in patients with communityacquired pneumonia. J Crit Care [Internet]. 2011;26(3):287–94. Available
from: http://dx.doi.org/10.1016/j.jcrc.2010.10.007 | en |
dcterms.references | Ugajin M, Yamaki K, Iwamura N, Yagi T, Asano T. Blood urea nitrogen to
serum albumin ratio independently predicts mortality and severity of
community-acquired pneumonia. Int J Gen Med. 2012;5:583–9. | en |
dcterms.references | Akpinar EE, Hosgun D DB et al. The role of albumin level and blood urea
nitrogen/albumin ratio in prediction of prognosis of community acquired
pneumonia. J Pulm Respir Med [Internet]. 2013;3(2):4–8. Available from:
http://dx.doi.org/10.4172/2161-105X. | en |
dcterms.references | Tokgoz Akyil F, Yalcinsoy M, Hazar A, Cilli A, Celenk B, Kilic O, et al.
Prognosis of hospitalized patients with community-acquired pneumonia. Rev
Port Pneumol (English Ed [Internet]. 2018;24(3):164–9. Available from:
http://dx.doi.org/10.1016/j.rppnen.2017.07.010 | en |
dcterms.references | Potter VAJ. Pulse oximetry in general practice: How would a pulse oximeter
influence patient management? Eur J Gen Pract. 2007;13(4):216–20. | en |
dcterms.references | Strålin K, Holmberg H, Mortensen E, Obrosky DS, Fine MJ. Causes of death
for patients with community-acquired pneumonia [3] (multiple letters). Arch
Intern Med. 2002;162(21):2491–3. | en |
dcterms.references | España PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, et al.
Development and validation of a clinical prediction rule for severe
community-acquired pneumonia. Am J Respir Crit Care Med.
2006;174(11):1249–56. | en |
dcterms.references | Wu CL, Lin FJ, Lee SY, Lee CH, Peng MJ, Chen PJ, et al. Early evolution of
arterial oxygenation in severe community-acquired pneumonia: A
prospective observational study. J Crit Care. 2007;22(2):129–36 | en |
dcterms.references | 1. Sanz F, Restrepo MI, Fernández E, Briones ML, Blanquer R, Mortensen EM,
et al. Is it possible to predict which patients with mild pneumonias will
develop hypoxemia? Respir Med. 2009;103(12):1871–7. | en |
dcterms.references | Mower WR, Sachs C, Nicklin EL, Safa P, Baraff LJ. Effect of routine
emergency department triage pulse oximetry screening on medical
management. Chest [Internet]. 1995;108(5):1297–302. Available from:
http://dx.doi.org/10.1378/chest.108.5.1297 | en |
dcterms.references | Blot SI, Rodriguez A, Solé-Violán J, Blanquer J, Almirall J, Rello J. Effects of
delayed oxygenation assessment on time to antibiotic delivery and mortality
in patients with severe community-acquired pneumonia. Crit Care Med.
2007;35(11):2509–14. | en |
dcterms.references | Ewig S, Ruiz M, Mensa J, Marcos MA, Martinez JA, Arancibia F, et al. | en |
dcterms.references | Myint PK, Kamath A V., Vowler SL, Maisey DN, Harrison BDW. Severity
assessment criteria recommended by the British Thoracic Society (BTS) for
community-acquired pneumonia (CAP) and older patients. Should SOAR
(systolic blood pressure, oxygenation, age and respiratory rate) criteria be
used in older people? A comp. Age Ageing. 2006;35(3):286–91. | en |
dcterms.references | Subramanian DN, Musonda P, Sankaran P, Tariq SM, Kamath A V., Myint
PK. Performance of SOAR (systolic blood pressure, oxygenation, age and
respiratory rate) scoring criteria in community-acquired pneumonia: A
prospective multi-centre study. Age Ageing. 2013;42(1):94–7. | en |
dcterms.references | Williams E, Girdwood J, Janus E, Karunajeewa H. CORB is the best
pneumonia severity score for elderly hospitalised patients with suspected
pneumonia. Intern Med J. 2014;44(66):613–5. | en |
dcterms.references | Martínez GM , Casas DP, Bastidas AR, Oliveros H, Pinilla PA, Calderón WJ
CF. Oxygen indexes as predictors of mechanical ventilation in pneumonia at
2600 meters above sea level. Acta Medica Colomb. 2016;41(3):169–75. | en |
dcterms.references | Lynch JP, Sitrin RG. Noninfectious mimics of community-acquired
pneumonia. Semin Respir Infect [Internet]. 1993;8(1):14–45. Available from:
http://dx.doi.org/10.1186/s41479-016-0002-1 | en |
dcterms.references | Garcia-Vidal C, Fernández-Sabé N, Carratalà J, Díaz V, Verdaguer R, Dorca
J, et al. Early mortality in patients with community-acquired pneumonia:
Causes and risk factors. Eur Respir J. 2008;32(3):733–9. | en |
dcterms.references | Lanks CW, Musani AI, Hsia DW. Community-acquired Pneumonia and
Hospital-acquired Pneumonia. Med Clin North Am [Internet].
2019;103(3):487–501. Available from:
https://doi.org/10.1016/j.mcna.2018.12.008 | en |
dcterms.references | Kwack WG, Lee DS, Min H, Choi YY, Yun M, Kim Y, et al. Evaluation of the
SpO2/FiO2 ratio as a predictor of intensive care unit transfers in respiratory
ward patients for whom the rapid response system has been activated. PLoS
One. 2018;13(7):1–11 | en |
dcterms.references | Roca O, Messika J, Caralt B, García-de-Acilu M, Sztrymf B, Ricard JD, et al.
Predicting success of high-flow nasal cannula in pneumonia patients with
hypoxemic respiratory failure: The utility of the ROX index. J Crit Care
[Internet]. 2016;35:200–5. Available from:
http://dx.doi.org/10.1016/j.jcrc.2016.05.022 | en |
dcterms.references | Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al.
Definitions , Mechanisms , Relevant Outcomes , and Clinical Trial
Coordination. Crit Care Med. 1994;149:818–24. | en |
dcterms.references | Luna CM, Blanzaco D, Niederman MS, Matarucco W, Baredes NC, Desmery
P, et al. Resolution of ventilator-associated pneumonia: Prospective
evaluation of the clinical pulmonary infection score as an early clinical
predictor of outcome. Crit Care Med. 2003;31(3):676–82. | en |
dcterms.references | Williams JM, Greenslade JH, Chu KH, Brown AFT, Lipman J. Utility of
community-acquired pneumonia severity scores in guiding disposition from
the emergency department: Intensive care or short-stay unit? EMA - Emerg
Med Australas. 2018;30(4):538–46. | en |
dcterms.references | Rice TW, Wheeler AP, Bernard GR, Hayden DL, Schoenfeld DA, Ware LB.
Comparison of the SpO2/FIO2 ratio and the PaO 2/FIO2 ratio in patients with
acute lung injury or ARDS. Chest. 2007;132(2):410–7. | en |
thesis.degree.discipline | Facultad de Medicina | es_CO |
thesis.degree.level | Especialización en Medicina Interna | es_CO |
thesis.degree.name | Especialista en Medicina Interna | es_CO |